EIX-IP Detection

Pharma-focused IP detection that integrates patents, science and real-world evidence
EIX-IP Detection, expert.ai's Pharma solution, delivers comprehensive, explainable insights across patents, scientific literature and clinical trial data.
Built with Hybrid-AI and tuned for life sciences, it empowers IP, legal and R&D teams to uncover hidden risks and opportunities early—before costly investments or regulatory filings. Unlike general-purpose IP platforms, EIX-IP Detection is purpose-built for Pharma, integrating seamlessly with research and regulatory workflows while safeguarding data and defensibility.


What it's for
In a world where innovation moves fast, traditional IP tools often miss critical early signals. Sparse, inconsistent information coming from multiple sources makes it difficult to build a clear view of IP activity. Weak signals, such as early-stage publications or niche patent filings, are often overlooked. Data consistency issues and the lack of explainability in analytics tools further slow decision making.
EIX-IP Detection is designed for Pharma IP, legal departments and R&D leaders. It helps legal teams provide explainable outputs for defensible litigation and compliance and provides R&D teams with needed early visibility of overlaps to protect costly development programs. Business leaders benefit from actionable competitive intelligence mapped to their key therapeutic areas.
EIX-IP Detection’s explainable AI and customizable analytics make it a valuable asset for strategic planning and legal defense.
With EIX-IP Detection, you can:
Strengthen legal and IP teams
Extend surveillance
Automate
Accelerate decision making
How it works
EIX-IP Detection is built on a framework designed for life sciences and pharmaceutical organizations. It is powered by Hybrid AI, a blend of symbolic AI, machine learning, and LLMs, enriched with curated life sciences data and deep Pharma domain expertise.
Integrated Data Coverage
Monitor patents, scientific publications and trial registries
AI Signal Detection
Spot weak signals using similarity and context-based algorithms
Explainable Insights
Evidence-backed outputs for legal and compliance defensibility
Configurable Taxonomies
Aligned with therapeutic areas and corporate IP strategy
Secure Access
Role-based, compliant deployment to protect sensitive Pharma data

Benefits
Proactive IP risk detection
across the Pharma innovation lifecycle
Comprehensive IP coverage
beyond patents, including science, clinical data and niche signals
Improved accuracy, efficiency and defensibility
for IP and legal teams
Faster, informed decision making
to protect investments and accelerate innovation
Strategic enablement
for Pharma legal and R&D leaders

AI you can explain. Outcomes you can measure.
Let expert.ai show you how to apply AI—securely, transparently and at scale.